Daniel Hochhauser

12.5k citations
152 papers · 7.7k · 4 hit papers · h-index 43

Impact in

  • Oncology top 0.5%
    • Pancreatic and Hepatic Oncology Research
    • PARP inhibition in cancer therapy
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

    • PARP inhibition in cancer therapy 18
    • Colorectal Cancer Treatments and Studies 11
    • Cancer-related Molecular Pathways 10
    • Pancreatic and Hepatic Oncology Research 10
    • Cancer therapeutics and mechanisms 31
    • DNA Repair Mechanisms 16

Daniel Hochhauser

143 papers receiving 7.5k citations

Daniel Hochhauser's Hit Papers

Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer 2022 · 129 citations
1290+2+5Years since publication50010001.5k

Peers

Daniel Hochhauser
Comparison fields: 5 of 146
  • Oncology 3.9k
  • Cancer Research 1.2k
  • Hepatology 301
  • Molecular Biology 2.5k
  • Pulmonary and Respiratory Medicine 977
Replace Manuel Modiano with:
Manuel Modiano United States
Haralabos P. Kalofonos Greece
Chris Twelves United Kingdom
Jean‐Pierre Armand France
Taylor Murray United States
Miguel A. Villalona‐Calero United States
Roberto Bianco Italy
Dick J. Richel Netherlands
Dorte Nielsen Denmark
J Carmichael United Kingdom
Daniel Hochhauser relative to Manuel Modiano United States Manuel Modiano's profile →
Citations per field
00.5×5.2×
Manuel Modiano · 1×
Citations per year

Countries citing papers authored by Daniel Hochhauser

Since Specialization
Citations

This map shows the geographic impact of Daniel Hochhauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hochhauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hochhauser more than expected).

Fields of papers citing papers by Daniel Hochhauser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Hochhauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hochhauser. The network helps show where Daniel Hochhauser may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Hochhauser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Hochhauser Line = papers co-authored together Daniel Hochhauser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer
Hit paper breakdown →
20191540
2
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2020779
3
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
Hit paper breakdown →
2018371
4 2011245
5 1992188
6 2015180
7 2010150
8 1996138
9 2004134
10
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Hit paper breakdown →
2022129
11 2002127
12 2013126
13 2019120
14 2004119
15 2019116
16 2013113
17 199597
18 199295
19 200293
20 200679

About Daniel Hochhauser

Daniel Hochhauser is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 152 papers that have together received 7.7k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (31 papers), PARP inhibition in cancer therapy (18 papers), DNA Repair Mechanisms (16 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer-related Molecular Pathways (10 papers), Pancreatic and Hepatic Oncology Research (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). The work is most often cited by research in Oncology (3.9k citations), Cancer Research (1.2k citations), Hepatology (301 citations), Molecular Biology (2.5k citations) and Pulmonary and Respiratory Medicine (977 citations). Daniel Hochhauser has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include John A. Hartley, Dirk Arnold, Adrian L. Harris, Eric Van Cutsem, Hedy L. Kindler, Michele Reni, Talia Golan, Teresa Macarulla, Michael J. Hall and Gershon Y. Locker. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, The Lancet and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact